Quarterly report pursuant to Section 13 or 15(d)

OPERATIONS AND MANAGEMENT PLANS

v3.21.1
OPERATIONS AND MANAGEMENT PLANS
3 Months Ended
Feb. 28, 2021
Adjustment for payable associated with patents  
OPERATIONS AND MANAGEMENT PLANS
2. OPERATIONS AND MANAGEMENT PLANS

 

From inception to February 28, 2021, the Company had incurred a cumulative loss of $50.5 million. The Company had funded operations through the issuance of common stock, warrants, and convertible notes payable. The Company generated $8.9 million in revenue during the three months ended February 28, 2021 but continues to incur a loss from operations. It still is expected to incur significant losses before the Company’s revenues sustains its operations. The Company’s future success is dependent upon its ability to generate adequate revenue or raise sufficient capital, to cover its ongoing operating expenses, and also to continue to develop and be able to profitably market its products.

 

The rapid growth of revenues and development of the production capacity to support them have substantially improved the Company’s operations and financial condition during the three months ended February 28, 2021. Sales increased by $8.7 million for the three months ended February 28, 2021 as compared to February 29, 2020, and cash and restricted cash has decreased by $5.4 million as of February 28, 2021 as compared to November 30, 2020. On January 19, 2021, the Company entered into a $5.0 million revolving line of credit, secured by the Company’s accounts receivable and inventory and another $1.5 million line of credit, secured by the Company’s equipment, with a bank. See Note 15, “Lines of Credit” for additional information. Management projects that all cash needs will be met beyond one year from the time these financial statements are issued.